Effects of Mitophagy on Regulatory T Cell Function in Patients With Myasthenia Gravis

被引:15
|
作者
Wang, Na [1 ]
Yuan, Jiang [1 ]
Karim, Md Rezaul [1 ,2 ]
Zhong, Ping [3 ]
Sun, Yan-Peng [1 ]
Zhang, Hong-Yan [1 ]
Wang, Yun-Fu [1 ,2 ]
机构
[1] Hubei Univ Med, Dept Neurol, Taihe Hosp, Shiyan, Peoples R China
[2] Hubei Univ Med, Biomed Res Inst, Shiyan, Peoples R China
[3] Hubei Univ Med, Dept Prevent Med, Shiyan, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
基金
中国国家自然科学基金;
关键词
myasthenia gravis; mitophagy; regulatory T cell; rapamycin; 3-methyladenine; IMMUNOSUPPRESSIVE THERAPY; AUTOPHAGY; MTOR; TREG; TACROLIMUS; SYSTEM; ROLES;
D O I
10.3389/fneur.2020.00238
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: This study was conducted to determine whether regulatory T cells (CD4(+)CD25(+)T, Tregs) show abnormal mitophagy as well as the function of Tregs in patients with myasthenia gravis (MG). Methods: CD4(+)T cells and CD4(+)CD25(+)Treg cells were obtained from 15 patients with MG (MG group) and 15 controls (N group). Tregs from the MG group were subjected to rapamycin-induced culture for 48 h (Rapa group) and 3-methyladenine-induced culture for 48 h (3-MA group). The levels of mitophagy in Tregs were then observed through electron and confocal microscopy. Expression of the autophagy-related protein LC3-II was detected by western blotting, and mitochondrial function in each group was evaluated by flow cytometry. Inhibition of Treg cell proliferation was detected by flow cytometry. Results: Mitophagy in the MG group was lower than that in the N group; it was higher in the Rapa group compared to that in the MG group and lowered in the 3-MA group than in the MG group. Expression of the autophagy-related protein LC3-II was lower in the MG group than in the N group, higher in the Rapa group than in the MG group, and lower in the 3-MA group than in the MG group. The mitochondrial membrane potential was lower in the MG group compared to that in the N group; it was higher in the Rapa group than in the MG group and lowered in the 3-MA group than in the MG group. Inhibition of Treg proliferation was lower in the MG group than in the N group; it was higher in the Rapa group than in the MG group and lowered in the 3-MA group than in the MG group. Conclusion: The decreased mitochondrial membrane potential and mitophagy in Tregs in the MG group may be related to a decreased inhibition of Treg proliferation. The mitochondrial membrane potential was increased after adding the autophagy agent Rapa to enhance mitophagy, and the proliferation inhibition function of Tregs was also enhanced. The autophagy agent 3-MA down-regulated mitophagy, which decreased the mitochondrial membrane potential and inhibitory effect of Tregs. These results reveal the possible cellular immune mechanism of Treg dysfunction in MG.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Impaired regulatory function in circulating CD4+CD25highCD127low/- T cells in patients with myasthenia gravis
    Thiruppathi, Muthusamy
    Rowin, Julie
    Ganesh, Balaji
    Sheng, Jian Rong
    Prabhakar, Bellur S.
    Meriggioli, Matthew N.
    CLINICAL IMMUNOLOGY, 2012, 145 (03) : 209 - 223
  • [42] B-CELL AND T-CELL ACTIVATION IN THE THYMUS OF PATIENTS WITH MYASTHENIA-GRAVIS
    COHENKAMINSKY, S
    LEPRINCE, C
    GALANAUD, P
    RICHARDS, Y
    BERRIH-AKNIN, S
    THYMUS, 1989, 14 (1-3) : 187 - 193
  • [43] Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis
    Chang, Ting
    Niu, Chunxiao
    Sun, Chao
    Ma, Ying
    Guo, Rongjing
    Ruan, Zhe
    Gao, Yanwu
    Lu, Xiaodan
    Li, Huanhuan
    Lin, Ye
    Lin, Jiaji
    Li, Zhuyi
    AGING-US, 2020, 12 (21): : 21147 - 21160
  • [44] CD4+CD25+ regulatory T cells are functionally deficient in patients with myasthenia gravis
    Luther, C
    Poeschel, S
    Varga, M
    Brucklacher, V
    Melms, A
    Tolosa, E
    JOURNAL OF NEUROLOGY, 2005, 252 : 24 - 24
  • [46] MYASTHENIA GRAVIS AND THYROID FUNCTION
    GAELEN, LH
    LEVITAN, S
    ARCHIVES OF NEUROLOGY, 1968, 18 (01) : 107 - &
  • [47] Stereotypic T cell receptor clonotypes in the thymus and peripheral blood of Myasthenia gravis patients
    Lee, Yonghee
    Kim, Seung Woo
    Lee, Eunjae
    Shin, Ha Young
    Kim, Mingi
    Lee, Chang Young
    Park, Byung Jo
    Kim, Ha Eun
    Yang, Young Ho
    Choi, Jinny
    Ju, Soyeon
    Park, Jungheum
    Kim, Namphil
    Choi, Jaewon
    Lee, Jin Gu
    Kwon, Sunghoon
    Chung, Junho
    HELIYON, 2024, 10 (04)
  • [48] T-CELL RECEPTOR EXPRESSION IN THE THYMUS FROM PATIENTS WITH MYASTHENIA-GRAVIS
    BERRIH-AKNIN, S
    COHENKAMINSKY, S
    TRUFFAULT, F
    T-CELL RECEPTOR USE IN HUMAN AUTOIMMUNE DISEASES, 1995, 756 : 438 - 440
  • [49] Myasthenia gravis - Maximizing function
    Kernich, Catherine A.
    NEUROLOGIST, 2008, 14 (01) : 75 - 76
  • [50] T-cell interleukin-6 receptor binding in patients with myasthenia gravis
    Bongioanni, P
    Ricciardi, R
    Romano, MR
    Murri, L
    Muratorio, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (02) : 215 - 220